H.R. 3537 – Reading Mode

IIB

114th CONGRESS

2d Session

H. R. 3537

IN THE SENATE OF THE UNITED STATES

September 27, 2016

Received; read twice and referred to the Committee on the Judiciary

AN ACT

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.

Short title

This Act may be cited as the Dangerous Synthetic Drug Control Act of 2016.

Treatment of certain designer drugs as schedule I controlled substances

(a)

Cannabimimetic agents

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)—

(1)

in clause (xiv) by striking and at the end;

(2)

in clause (xv) by striking the period and inserting a semicolon; and

(3)

by adding at the end the following:

(xvi)

2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251);

(xvii)

(1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073);

(xviii)

2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302);

(xix)

N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA);

(xx)

quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22);

(xxi)

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA);

(xxii)

N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24);

(xxiii)

(1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201);

(xxiv)

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA);

(xxv)

methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and

(xxvi)

methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA).

(b)

Synthetic opioids

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following:

(43)

Butyryl fentanyl.

(44)

beta-Hydroxythiofentanyl.

(45)

Acetyl fentanyl.

(c)

Other drugs

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following:

(29)

1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone).

(30)

1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB).

(31)

1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB).

(32)

6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).

(33)

5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI).

(34)

1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly).

(35)

1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC).

(36)

1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM).

Passed the House of Representatives September 26, 2016.

Karen L. Haas,

Clerk.